JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Update

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the target of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 590,800 shares, a decrease of 6.0% from the March 15th total of 628,800 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

JCR Pharmaceuticals Price Performance

OTCMKTS:JCRRF opened at $5.22 on Wednesday. The company has a 50 day simple moving average of $6.48 and a two-hundred day simple moving average of $8.16. JCR Pharmaceuticals has a fifty-two week low of $5.22 and a fifty-two week high of $6.20.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.